Abstract
Using two colour immunofluorescence with fluorescein isothiocyanate and phycoerythrin labelled monoclonal antibodies, multi-parameter flow cytometry was used to examine the antigenic characteristics of peripheral blood lymphocytes in whole blood of patients with ulcerative colitis and Crohn's disease who were not taking immunosuppressive drugs. The numbers of CD4+ and CD8+ lymphocytes in patients with ulcerative colitis and Crohn's disease remained unchanged so that the CD4/CD8 ratio was the same as that of normal control subjects. In Crohn's disease there were many activated T cells (CD3+, CD25+). Although natural killer cells in active Crohn's disease were lower than in normal control subjects, cytotoxic T lymphocytes, as defined by CD3+, CD16+, did not differ in patients with inflammatory bowel disease compared with normal control subjects. For B cell subsets, there were differences in Leu-1+ B cells, Leu-8+ B cells, Fc epsilon R+B cells (Leu-16+, Leu-20+), and activated B cells (Leu-12+, Leu-21+) between patients with inflammatory bowel disease and normal control subjects. These differences are compatible with local activation of B cells in the inflamed colon.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Auer I. O., Röder A., Fröhlich J. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets. Gastroenterology. 1984 Jun;86(6):1531–1543. [PubMed] [Google Scholar]
- Davidsen B., Kristensen E. Lymphocyte subpopulations, lymphoblast transformation activity, and concanavalin A-induced suppressor activity in patients with ulcerative colitis and Crohn's disease. Scand J Gastroenterol. 1987 Sep;22(7):785–790. doi: 10.3109/00365528708991915. [DOI] [PubMed] [Google Scholar]
- De Dombal F. T., Burton I. L., Clamp S. E., Goligher J. C. Short-term course and prognosis of Crohn's disease. Gut. 1974 Jun;15(6):435–443. doi: 10.1136/gut.15.6.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Godin N. J., Sachar D. B., Winchester R., Simon C., Janowitz H. D. Loss of suppressor T-cells in active inflammatory bowel disease. Gut. 1984 Jul;25(7):743–747. doi: 10.1136/gut.25.7.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Griffin J. D., Hercend T., Beveridge R., Schlossman S. F. Characterization of an antigen expressed by human natural killer cells. J Immunol. 1983 Jun;130(6):2947–2951. [PubMed] [Google Scholar]
- James S. P., Fiocchi C., Graeff A. S., Strober W. Phenotypic analysis of lamina propria lymphocytes. Predominance of helper-inducer and cytolytic T-cell phenotypes and deficiency of suppressor-inducer phenotypes in Crohn's disease and control patients. Gastroenterology. 1986 Dec;91(6):1483–1489. [PubMed] [Google Scholar]
- James S. P., Neckers L. M., Graeff A. S., Cossman J., Balch C. M., Strober W. Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn's disease. Gastroenterology. 1984 Jun;86(6):1510–1518. [PubMed] [Google Scholar]
- Kansas G. S., Wood G. S., Fishwild D. M., Engleman E. G. Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-leu-8. J Immunol. 1985 May;134(5):2995–3002. [PubMed] [Google Scholar]
- Lanier L. L., Le A. M., Civin C. I., Loken M. R., Phillips J. H. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol. 1986 Jun 15;136(12):4480–4486. [PubMed] [Google Scholar]
- Lanier L. L., Le A. M., Phillips J. H., Warner N. L., Babcock G. F. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol. 1983 Oct;131(4):1789–1796. [PubMed] [Google Scholar]
- Lanier L. L., Phillips J. H., Hackett J., Jr, Tutt M., Kumar V. Natural killer cells: definition of a cell type rather than a function. J Immunol. 1986 Nov 1;137(9):2735–2739. [PubMed] [Google Scholar]
- Ledbetter J. A., Rose L. M., Spooner C. E., Beatty P. G., Martin P. J., Clark E. A. Antibodies to common leukocyte antigen p220 influence human T cell proliferation by modifying IL 2 receptor expression. J Immunol. 1985 Sep;135(3):1819–1825. [PubMed] [Google Scholar]
- Legendre C. M., Guttmann R. D., Hou S. K., Jean R. Two-color immunofluorescence and flow cytometry analysis of lymphocytes in long-term renal allotransplant recipients: identification of a major Leu-7+/Leu-3+ subpopulation. J Immunol. 1985 Aug;135(2):1061–1066. [PubMed] [Google Scholar]
- Morimoto C., Letvin N. L., Distaso J. A., Aldrich W. R., Schlossman S. F. The isolation and characterization of the human suppressor inducer T cell subset. J Immunol. 1985 Mar;134(3):1508–1515. [PubMed] [Google Scholar]
- Morimoto C., Reinherz E. L., Schlossman S. F., Schur P. H., Mills J. A., Steinberg A. D. Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. J Clin Invest. 1980 Nov;66(5):1171–1174. doi: 10.1172/JCI109948. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pallone F., Montano S., Fais S., Boirivant M., Signore A., Pozzilli P. Studies of peripheral blood lymphocytes in Crohn's disease. Circulating activated T cells. Scand J Gastroenterol. 1983 Nov;18(8):1003–1008. doi: 10.3109/00365528309181833. [DOI] [PubMed] [Google Scholar]
- Pepys E. O., Fagan E. A., Tennent G. A., Chadwick V. S., Pepys M. B. Enumeration of lymphocyte populations defined by surface markers in the whole blood of patients with Crohn's disease. Gut. 1982 Sep;23(9):766–769. doi: 10.1136/gut.23.9.766. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Raeman F., De Cock W., De Beukelaar T., De Cree J., Verhaegen H. Enumeration of T lymphocytes subsets in autoimmune disease using monoclonal antibodies. Clin Exp Immunol. 1981 Sep;45(3):475–479. [PMC free article] [PubMed] [Google Scholar]
- Selby W. S., Jewell D. P. T lymphocyte subsets in inflammatory bowel disease: peripheral blood. Gut. 1983 Feb;24(2):99–105. doi: 10.1136/gut.24.2.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- TRUELOVE S. C., WITTS L. J. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955 Oct 29;2(4947):1041–1048. doi: 10.1136/bmj.2.4947.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Van Gossum A., Dupont E., Schandene L., Cremer M., Wybran J. Immune status in healthy relatives of patients with familial Crohn's disease. Dig Dis Sci. 1988 Aug;33(8):945–950. doi: 10.1007/BF01535989. [DOI] [PubMed] [Google Scholar]
- Yu D. T., Winchester R. J., Fu S. M., Gibofsky A., Ko H. S., Kunkel H. G. Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization. J Exp Med. 1980 Jan 1;151(1):91–100. doi: 10.1084/jem.151.1.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yuan S. Z., Hanauer S. B., Kluskens L. F., Kraft S. C. Circulating lymphocyte subpopulations in Crohn's disease. Gastroenterology. 1983 Dec;85(6):1313–1318. [PubMed] [Google Scholar]